Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Investigating the potential role of regulator of G protein signaling (RGS9-2) in the nucleus accumbens as a therapeutic target for neuropathic pain induced depression.
FY 2013-14
Summary
According to the Chronic Pain Association of Canada, 1 in 5 Canadians are suffering from some form of severe, recurring pain. The estimated cost of chronic pain to the Canadian economy is $10 billion per year. Twenty percent of individuals suffering from chronic pain also suffer from depression, and these patients report increases in depression in correspondence with increases in their pain. Although several therapeutic interventions exist for chronic pain and depression, their benefit is overshadowed by their abundant side effects. Furthermore, therapeutic strategies that target both the pain and depression symptoms associated with chronic pain are lacking. This proposal examines the impact of a brain region, the nucleus accumbens (NAc), which is involved in mood. This brain region is strongly implicated in depression and antidepressant drug actions. The proposed research will investigate how this brain region is involved in the pain, anxiety, and depression associated with chronic pain, and how these activities are affected by antidepressants. Most of the knowledge of chronic pain and its treatment derives from studies on spinal cord mechanisms, or studies of brain structures involved in sensory transmission. Recent work shows that antidepressants can reduce chronic pain, and that they act in several brain regions. Understanding the molecular effects antidepressants have in a brain region involved in mood will elucidate the signaling processes contributing to both chronic pain and depression. I will apply cutting edge methodologies to characterize the mechanism by which antidepressants alter chronic pain and depression symptoms via the NAc. By exploring at the molecular and cellular level how this region is affected in chronic pain and how it responds to antidepressants, I seek to improve current therapies targeting chronic pain and depressed patients.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
297000
Name
Descalzi Giannina
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Investigating the potential role of regulator of G protein signaling (RGS9-2) in the nucleus accumbens as a therapeutic target for neuropathic pain induced depression.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Behavior; Chronic Pain; Depression; Nucleus Accumbens; Qpcr; Viral Mediated Gene Transfer; Western Blot
Abstract
According to the Chronic Pain Association of Canada, 1 in 5 Canadians are suffering from some form of severe, recurring pain. The estimated cost of chronic pain to the Canadian economy is $10 billion per year. Twenty percent of individuals suffering from chronic pain also suffer from depression, and these patients report increases in depression in correspondence with increases in their pain. Although several therapeutic interventions exist for chronic pain and depression, their benefit is overshadowed by their abundant side effects. Furthermore, therapeutic strategies that target both the pain and depression symptoms associated with chronic pain are lacking. This proposal examines the impact of a brain region, the nucleus accumbens (NAc), which is involved in mood. This brain region is strongly implicated in depression and antidepressant drug actions. The proposed research will investigate how this brain region is involved in the pain, anxiety, and depression associated with chronic pain, and how these activities are affected by antidepressants. Most of the knowledge of chronic pain and its treatment derives from studies on spinal cord mechanisms, or studies of brain structures involved in sensory transmission. Recent work shows that antidepressants can reduce chronic pain, and that they act in several brain regions. Understanding the molecular effects antidepressants have in a brain region involved in mood will elucidate the signaling processes contributing to both chronic pain and depression. I will apply cutting edge methodologies to characterize the mechanism by which antidepressants alter chronic pain and depression symptoms via the NAc. By exploring at the molecular and cellular level how this region is affected in chronic pain and how it responds to antidepressants, I seek to improve current therapies targeting chronic pain and depressed patients.
Competitiondate
201310
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Descalzi, Giannina
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~